Jarle Christensen I - Search Results

1

Diagnostic challenges in clinical, radiological and histopathological tests regarding papillomatous lesions of the breast.

Rasmussen BB, Balslev E, Jarle Christensen I, Lanng C, Bak A, Galatius H, Møller Talman ML, Sharghi Someh N, Vejborg I, Okholm M. Rasmussen BB, et al. Among authors: jarle christensen i. Breast. 2018 Aug;40:177-180. doi: 10.1016/j.breast.2018.05.006. Epub 2018 May 22. Breast. 2018. PMID: 29906740

2

HE4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancer.

Aarenstrup Karlsen M, Høgdall C, Nedergaard L, Philipsen Prahm K, Schou Karlsen NM, Weng Ekmann-Gade A, Henrichsen Schnack T, Svenstrup Poulsen T, Jarle Christensen I, Høgdall E. Aarenstrup Karlsen M, et al. Among authors: jarle christensen i. APMIS. 2016 Dec;124(12):1038-1045. doi: 10.1111/apm.12625. Epub 2016 Nov 16. APMIS. 2016. PMID: 27859687

3

Tetranectin positive expression in tumour tissue leads to longer survival in Danish women with ovarian cancer. Results from the 'Malova' ovarian cancer study.

Heeran MC, Rask L, Høgdall CK, Kjaer SK, Christensen L, Jensen A, Blaakaer J, Jarle Christensen IB, Høgdall EV. Heeran MC, et al. Among authors: jarle christensen ib. APMIS. 2015 May;123(5):401-9. doi: 10.1111/apm.12368. Epub 2015 Apr 4. APMIS. 2015. PMID: 25846370

4

Increased serological, cancer-associated protein biomarker levels at diagnosis of large bowel adenoma: Risk of subsequent primary malignancy?

Piper TB, Jørgensen LN, Olsen J, Nielsen KT, Davis G, Johansen JS, Jarle Christensen I, Nielsen HJ. Piper TB, et al. Among authors: jarle christensen i. Acta Oncol. 2019;58(sup1):S42-S48. doi: 10.1080/0284186X.2018.1540885. Epub 2018 Dec 7. Acta Oncol. 2019. PMID: 30523734

5

Protein expression levels of carcinoembryonic antigen (CEA) in Danish ovarian cancer patients: from the Danish 'MALOVA'ovarian cancer study.

Høgdall EV, Christensen L, Kjaer SK, Blaakaer J, Jarle Christensen I, Gayther S, Jacobs IJ, Høgdall CK. Høgdall EV, et al. Among authors: jarle christensen i. Pathology. 2008 Aug;40(5):487-92. doi: 10.1080/00313020802197889. Pathology. 2008. PMID: 18604735

6

Reply to C. Rusner et al, L.C. Pagliaro et al, and K. Lu.

Daugaard G, Kier MG, Mortensen MS, Agerbæk M, Holm NV, Rørth M, von der Maase H, Jarle Christensen I, Lauritsen J. Daugaard G, et al. Among authors: jarle christensen i. J Clin Oncol. 2015 Jul 10;33(20):2326-7. doi: 10.1200/JCO.2015.60.9313. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033816 No abstract available.

7

Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment.

Møller Sørensen N, Vejgaard Sørensen I, Ørnbjerg Würtz S, Schrohl AS, Dowell B, Davis G, Jarle Christensen I, Nielsen HJ, Brünner N. Møller Sørensen N, et al. Among authors: jarle christensen i. Scand J Gastroenterol. 2008;43(7):774-86. doi: 10.1080/00365520701878163. Scand J Gastroenterol. 2008. PMID: 18584515 Review.

8

Surgery After Relapse in Stage I Nonseminomatous Testicular Cancer.

Daugaard G, Gundgaard MG, Mortensen MS, Agerbæk M, Holm NV, Rørth MR, von der Maase H, Jarle Christensen I, Lauritsen J. Daugaard G, et al. Among authors: jarle christensen i. J Clin Oncol. 2015 Jul 10;33(20):2322. doi: 10.1200/JCO.2014.60.2177. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033809 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page